Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

AKR7A3 gene

Known as: AFAR2, AKR7A3, aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Individuals with type 2 diabetes (T2D) and dyslipidemia are at an increased risk of cardiovascular disease. Fibrates are a class… 
2018
2018
BackgroundThe intrinsic heterogeneity of hepatocellular carcinoma (HCC) represents a great challenge for its molecular… 
  • figure 1
  • figure 3
  • figure 4
  • table 1
  • figure 5
2017
2017
This study aims to clarify the relationship and mechanism between expression of autophagy‐related protein P62 and prognosis of… 
2017
2017
Hepatocellular carcinoma (HCC), which accounts for 85–90% of primary liver cancer, is now the second leading cause of cancer… 
2016
2016
Hepatocellular carcinoma (HCC), which accounts for 85-90% of primary liver cancer, is now the second leading cause of cancer… 
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
2014
2014
AbstractMetabolism of anticancer drugs affects their antitumor effects. This study has investigated the associations of gene… 
2014
2014
OBJECTIVE To explore associated proteins involved in age-related changes of the testis and better understand the roles of these… 
2011
2011
Aldo‐keto reductase‐7A (AKR7A) is an enzyme important for bioactivation and biodetoxification. Previous studies suggested that… 
2008
2008
The reduction of the aflatoxin B 1 (AFB 1) dialdehyde metabolite to its corresponding mono and dialcohols, catalyzed by aflatoxin… 
Highly Cited
1999
Highly Cited
1999
The aflatoxin B1 (AFB1) aldehyde metabolite of AFB1 may contribute to the cytotoxicity of this hepatocarcinogen via protein… 
  • figure 1
  • figure 2
  • figure 3
  • table I
  • figure 4